Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

479
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
479
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial transcriptomics reveals coordinated ventricular patterning and maturation in the developing human heart.

Nature communications·2026
Same author

Mitochondrial DNA heteroplasmy drives cortical neuronal disturbances in human organoids harbouring the common m.3243A>G mutation.

Nature communications·2026
Same author

Cardiac immunity and heart repair: Mechanism, challenge, and future direction.

Chinese medical journal·2026
Same author

Dearomative [3,3]-Claisen Rearrangement of 2-Indolyl Alcohols: An Efficient and General Protocol for Synthesizing 3,3-Disubstituted Indolines and Related Indole Alkaloids.

Angewandte Chemie (International ed. in English)·2026
Same author

Sub-voxel Susceptibility Mapping and Machine Learning to Detect Brain Iron Deposition and Its Cognitive Relevance in Beta-Thalassemia.

AJNR. American journal of neuroradiology·2026
Same author

CardioNVT: an AI platform for immunostaining-free, high-throughput cardiomyocyte ploidy assessment in situ.

Science bulletin·2026

Related Experiment Video

Updated: Aug 9, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

4.7K

Targeting immunoregulation for cardiac regeneration.

Ruopu Li1, Chenying Xiang1, Yixun Li1

  • 1State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.

Journal of Molecular and Cellular Cardiology
|February 21, 2023
PubMed
Summary

Targeting the immune response can promote heart regeneration after injury. This review explores how inflammation influences cardiac repair, identifying key immune targets for improving heart function post-myocardial infarction.

Keywords:
Cell transplantationHeart regenerationImmune responseInflammationInterleukin-6Myocardial injury

More Related Videos

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
09:25

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Published on: May 8, 2020

8.0K
Transplantation of Neonatal Mouse Cardiac Macrophages into Adult Mice
06:10

Transplantation of Neonatal Mouse Cardiac Macrophages into Adult Mice

Published on: March 20, 2021

2.9K

Related Experiment Videos

Last Updated: Aug 9, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

4.7K
An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
09:25

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Published on: May 8, 2020

8.0K
Transplantation of Neonatal Mouse Cardiac Macrophages into Adult Mice
06:10

Transplantation of Neonatal Mouse Cardiac Macrophages into Adult Mice

Published on: March 20, 2021

2.9K

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Regenerative Medicine

Background:

  • Ischemic heart failure is a major cause of mortality.
  • Endogenous cardiomyocyte proliferation is key to heart regeneration.
  • The immune system plays a critical role in cardiac repair post-injury.

Purpose of the Study:

  • To review the relationship between post-injury immune response and cardiac regenerative capacity.
  • To summarize recent studies on inflammation and heart regeneration.
  • To identify immune targets and strategies for promoting cardiac regeneration.

Main Methods:

  • Literature review of studies on immune response and cardiac regeneration.
  • Analysis of the role of inflammation in myocardial repair.
  • Identification of potential therapeutic targets within the immune system.

Main Results:

  • The immune response is critical for endogenous cardiomyocyte proliferation.
  • Inflammation dynamics post-myocardial infarction influence regenerative capacity.
  • Specific immune cells and pathways are key regulators of heart repair.

Conclusions:

  • Modulating the immune response is a promising strategy for treating ischemic heart failure.
  • Targeting inflammation can enhance cardiac regeneration and repair.
  • Further research into immune-based therapies holds potential for improving outcomes after myocardial infarction.